Announcements Trials
Browse Landscape

Phase

Phase 2 11Phase 1 7Phase 3 4Phase 1/2 4Phase EARLY_PHASE1 2Phase 4 2Phase NA 1

Status

Unknown 2

Sponsor Class

OTHER 44INDUSTRY 9OTHER_GOV 2NIH 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 2

Conditions

Solid Tumors 1Solid Tumor 1

Interventions

fludarabine 2Interleukin-2 2Cyclophosphamide 2toripalimab 1lenvatinib 1epigallocatechin gallate 1avelumab 1Zinc 1Tissue Banks 1Quercetin 1Pemetrexed 1Paclitaxel 1Optical Fibers 1Metformin 1Ethiodized Oil 1Docetaxel 1Dihematoporphyrin Ether 1Cisplatin 1Carboplatin 1Blood Specimen Collection 1Biopsy, Needle 1Bevacizumab 1Albumin-Bound Paclitaxel 12-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × OTHER_GOV × Cyclophosphamide × Clear all
NCT05649618 2022-12-14

TIL Cells for the Treatment of the Advanced Solid Tumors Patients

Fujian Cancer Hospital

Phase EARLY_PHASE1 Unknown
42 enrolled
Other solid neoplasm

Solid Tumor

NCT05648994 2022-12-13

TCR-T Cells for the Treatment NY-ESO-1-positive Advanced Solid Tumors

Fujian Cancer Hospital

Phase EARLY_PHASE1 Unknown
30 enrolled
Other solid neoplasm

Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡